Repeat ultrasound guided prostate needle biopsy: Use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma

Journal of Urology

Volumn 160, Issue 2, 1998, Pages 426-429

  Letran, Jason L ^a   Blase, Amy B ^a   Loberiza, Fausto R ^a   Meyer, Grant E ^a   Ransom, Sean D ^a   Brawer, Michael K ^a  

^a Northwest Prostate Institute   (United States)

Author keywords

Biopsy, needle; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; ECHOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA;

EID: 0032322194     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62915-X     Document Type: Article

References (20)

1. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate specific antigen-based screening. J.A.M.A., 270: 948, 1993.
2. Keetch, D. W., Catalona, W. J. and Smith, D. S.: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol., 151: 1571, 1994.
3. Roerhborn, C. G., Pickens, G. J. and Sanders, J. S.: Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate-specific antigen levels. Urology, 47: 347, 1996.
4. Ellis, W. J. and Brawer, M. K: Repeat prostate needle biopsy: who needs it? J. Urol., 153: 1496, 1995.
5. Christensson, A., Laurell, C. B. and Lilja, H.: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem., 194: 755, 1990.
6. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K. and Alfthan, O.: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222, 1991.
7. Luderer, A. A., Chen, Y. T., Soriano, T. F., Kramp, W. J., Carlson, G., Cuny, C., Sharp, T., Smith, W., Petteway, J. C., Brawer. M. K. and Thiel, R.: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995.
8. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
9. Bangma, C. H., Kranse, R., Blijenberg, B. G. and Schröder, F. H.: The value of screening tests in the detection of prostate cancer. Part I: results of a retrospective evaluation of 1726 men. Urology, 46: 773, 1995.
10. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Patel, A., Flanigan, R. C., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Herschman, J. D., Subong, E. N. P., Petteway, J. C., Parson, R. E., Loveland, K. G., Gasior, G. H. and Southwick, P. C.: A multicenter clinical trial evaluation of free PSA in the differentiation of prostate cancer from benign disease. J. Urol., part 2, 157: 111, abstract 434, 1997.
11. Benson, M. C. and Olsson, C. A.: Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management. Cancer, 74: 1667, 1994.
12. Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, J. L. and Walsh, P. C.: Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. J.A.M.A., 267: 2215, 1992.
13. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
14. Brawer, M. K., Aramburu, E. A. G., Chen, G. L., Preston, S. D. and Ellis, W. J.: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J. Urol., 150: 369, 1993.
15. Catalona, W. J., Richie, J. P., deKernion, J. B., Ahmann, F. R., Ratliff, T. L., Dalkin, B. L., Kavoussi, L. R., MacFarlane, M. T. and Soutwick, P. C.: Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J. Urol., 152: 2031, 1994.
16. Nixon, R. G., Lilly, J. D., Liedtke, R. J. and Batjer, J. D.: Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen. Arch. Path. Lab. Med., 121: 385, 1997.
17. Etzioni, R., Shen, Y., Petteway, J. C. and Brawer, M. K.: Age-specific prostate-specific antigen: a reassessment. Prostate, suppl., 7: 70, 1996.
18. Morgan, T. O., McLeod, D. G., Leifer, E. S., Murphy, G. P. and Moul, J. W.: Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen. Urology, 48: 76, 1996.
19. Brawer, M. K., Bankson, D. D., Haver, V. M. and Petteway, J. C.: Comparison of three commercial PSA assays: results of restandardization of the Ciba Corning method. Prostate, 30: 269, 1997.
20. Nixon, R. G., Petteway, J. C., Meyer, G. E. and Brawer, M. K.: Comparison of three investigative assays for the free form of prostate-specific antigen. J. Urol., part 2, 157: 255, abstract 999, 1997.